Projekt

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis

Laufend - Rekrutierung – laufend · 2024 bis 2027

Neuwirth Christoph